SENSITIZATION TO EUXYL-K400, A PROSPECTIVE-STUDY IN 1,217 PATIENTS

Citation
M. Vigan et al., SENSITIZATION TO EUXYL-K400, A PROSPECTIVE-STUDY IN 1,217 PATIENTS, EJD. European journal of dermatology, 6(3), 1996, pp. 175-177
Citations number
22
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
11671122
Volume
6
Issue
3
Year of publication
1996
Pages
175 - 177
Database
ISI
SICI code
1167-1122(1996)6:3<175:STEAPI>2.0.ZU;2-3
Abstract
Euxyl K400 is a biocide used in cosmetics. It is composed of phenoxyet hanol and dibromodicyanobutane. From January of 1988 to October of 199 4, 1,217 patients with contact dermatitis were tested with Euxyl K400, 2% petrolatum. This study had three aims: to monitor and record the e volution of the rate of sensitization, to study the sensitized populat ion, to determine the sensitizing compound present in Euxyl K400. The rate of sensitization increased; animal studies were not able to predi ct this sensitization; this fact shows the interest of ''active cosmet ovigilance''. Dibromodicyanobutane is the main allergen in Euxyl K400 but it is not the only one.